Hopen Life Science Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Hopen Life Science Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2022	Delphinus Medical Technologies	$30.0M Series D	—	Beringea, Galen Partners, Paul McCreadie, North Coast Technology Investors, Venture Investors, Waycross Ventures
Apr 11, 2017	Cirius Therapeutics	$40.0M Series A	Daniel Estes, Nilesh Kumar	Adams Street Partners, Renaissance Venture Capital Fund
Sep 1, 2015	Delphinus Medical Technologies	$40.0M Series C	John Neis	Beringea, Galen Partners, Arboretum Ventures, North Coast Technology Investors, Waycross Ventures
Jun 1, 2015	NeoChord	$20.0M Series C	Avi Kometz	Arboretum Ventures, Baird Capital, Endeavor Venture Funds, CHV Capital, Heron Capital, Michael Fulton, TGap Ventures
Apr 7, 2014	Bjond	$3.3M Series A	Will Indest	TriStar Technology Ventures
Apr 1, 2014	Sierra Oncology	$60.0M Series D	Albert Cha	Frazier Healthcare Partners, OrbiMed, Sofinnova Investments, VantagePoint Capital Partners, Amherst Fund, Donald Parfet, Alvin Vitangcol, Caxton Alternative Management, Grand Angels, Janus Henderson Investors, RA Capital Management, Sectoral Asset Management
Oct 17, 2012	Tolera Therapeutics	$5.5M Series B	Robert Hackenberg	SWMF Life Science Fund, Triathlon Medical Ventures
Jul 1, 2011	Trapelo Health	$7.0M Series B	Beringea, Koleman Karleski	Michigan Accelerator Fund